Please find attached herewith our response on Clarification sought by BSE from the Company on significant movement in volume of shares of the Company
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
BSE asked Thyrocare Technologies to explain a sudden spike in the trading volume of its shares. In its response dated November 14, 2025, the company said it is not aware of any specific reason for the volume increase and that the rise is 'purely market driven.' The management stated it has no connection with the unusual trading activity. Thyrocare also reaffirmed that it has been regularly disclosing all material information to the stock exchanges as required under SEBI's Listing Regulations and remains compliant with applicable laws.
For shareholders, this is essentially a 'no comment on the cause' response — the company is distancing itself from the volume surge, which means there is no disclosed corporate trigger (such as results, orders, or M&A) behind the price/volume action. This typically keeps the stock under exchange surveillance but does not, on its own, signal any negative corporate development.